SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-139108
Filing Date
2020-05-11
Accepted
2020-05-11 16:31:03
Documents
5
Effectiveness Date
2020-05-11

Document Format Files

Seq Description Document Type Size
1 S-8 d921794ds8.htm S-8 61051
2 EX-4.3 d921794dex43.htm EX-4.3 28964
3 EX-5.1 d921794dex51.htm EX-5.1 11513
4 EX-23.1 d921794dex231.htm EX-23.1 2422
5 GRAPHIC g921794g42n47.jpg GRAPHIC 3084
  Complete submission text file 0001193125-20-139108.txt   109387
Mailing Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801
Business Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801 (857) 444-0553
Ayala Pharmaceuticals, Inc. (Filer) CIK: 0001797336 (see all company filings)

IRS No.: 823578375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-238165 | Film No.: 20865305
SIC: 2836 Biological Products, (No Diagnostic Substances)